Novo Nordisk's higher-dose Wegovy has arrived. Following regulatory approval, Wegovy 7.2mg is now available through private providers, offering a new option for people who need more support than the standard 2.4mg dose.
Until now, the maximum licensed dose of Wegovy has been 2.4mg. But new trial data from the STEP UP trials shows that this higher strength offers significantly greater weight loss results, rivalling medications like Mounjaro.
Here's what you need to know about Wegovy 7.2mg: the trial data, who it's for, how it compares to existing doses, and how to access it.
Key Takeaways
- New maximum Wegovy dose: 7.2mg is now approved and available in the UK as the highest licensed strength
- Average weight loss: up to 20.7% in STEP UP trials
- How it compares: similar to Mounjaro 15mg
- UK availability: Now available through private providers like Voy. The dedicated 7.2mg pen isn't available yet, so you'll use three 2.4mg pens per month
- Who it's for: people on Wegovy 2.4mg who have plateaued and tolerate semaglutide well
- Side effects: mainly digestive such as nausea, constipation and diarrhoea, consistent with lower doses
How to access Wegovy 7.2mg
Wegovy 7.2mg is now approved and available in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) approved the 7.2mg dose in January 2026, and you can access it through private providers like Voy. NHS availability is expected to follow later.
While the dedicated 7.2mg pen isn't available just yet (it's expected sometime this year), there's no need to wait. Your clinician can prescribe 7.2mg using 2.4mg pens instead. You'll receive three 2.4mg pens per month, which gives you the full 7.2mg dose you need.
How much will it cost?
Wegovy 7.2mg is available through Voy with the following pricing options:
- Monthly plan: £409 per month
- 3-month plan: £399 per month
- 6-month plan: £389 per month
- 12-month plan: £385 per month
All plans include your medication (three 2.4mg pens per month to achieve the 7.2mg dose), clinical support, and access to Voy's full weight loss programme with coaching, in-app tools, and expert content.
How to give a 7.2mg dose using 2.4mg pens
To achieve the full 7.2mg dose, you'll need to give yourself three separate 2.4mg injections using your current pen. Here's how:
- First injection (2.4mg) - Attach a new needle, dial to 2.4mg, choose an injection site, and inject as normal
- Second injection (2.4mg) - Remove and discard the used needle, attach a new needle, choose a different injection site, dial to 2.4mg and inject
- Third injection (2.4mg) - One more fresh needle, another new injection site, dial to 2.4mg, and you're done
The key is rotating between different spots each time. You can stay within the same area (like your abdomen) and just move to a different spot, or switch between different areas (stomach, thigh, upper arm). This helps prevent irritation and keeps things comfortable.
If you're new to Wegovy injections or want a refresher, check out our how to inject Wegovy guide.
Wegovy 7.2mg: results and how it compares
In trials Wegovy 7.2 mg averaged 20.7% weight loss versus 17.5% for Wegovy 2.4 mg and 22.5% for Mounjaro 15 mg.
Wegovy 2.4mg is already proven to help many people lose significant weight, but it can take time for some to reach their goals on that dose. For those who plateau or need a stronger appetite suppressant, Wegovy 7.2mg could be a game changer.
Two new trials STEP UP and STEP UP T2D looked at the 7.2mg dose in people with obesity, with and without type 2 diabetes. The results were striking:
- Average total weight loss: up to 20.7% of body weight
- Around one-third of users lost 25% or more of their starting weight
- Data also showed that semaglutide 7.2mg was well tolerated, with a safety profile consistent with the 2.4mg dose and earlier semaglutide trials from Novo Nordisk
This places Wegovy 7.2mg in the same league as Mounjaro 15mg in terms of outcomes.
For comparison:
Thinking about switching? Compare weight loss options.
Who might benefit from Wegovy 7.2mg?
Wegovy 7.2mg is designed for people who need more support than the standard 2.4mg dose. It’s not a starting dose, but it could be the right next step if your progress has slowed or plateaued and you’re still tolerating semaglutide well.
This dose has been specifically studied for people who hadn’t achieved sufficient weight loss on lower doses of semaglutide. If that sounds like your experience, intensifying treatment with 7.2mg could help you get back on track.
You may be a good candidate if:
- You're currently on Wegovy 2.4mg, and your weight loss has plateaued.
- You’re tolerating semaglutide well, with mild or manageable side effects.
- You’ve been using Mounjaro but haven't seen the results you expected and you're considering switching to Wegovy.
- You’re experiencing side effects on Mounjaro and want to explore an alternative weight loss treatment.
Just a note: Wegovy 7.2mg isn’t a starting dose. If you’re switching from Mounjaro or beginning treatment with Wegovy for the first time, you’ll need to follow a titration plan agreed with your clinician before becoming eligible for this higher dose.
Can I switch to Wegovy 7.2mg?
Yes, Wegovy 7.2mg is now available in the UK. There are a few different routes you might take to reach it, depending on your current treatment.
If you're already using Wegovy:
You may be able to move up to 7.2mg if you’re currently on the 2.4mg dose and need a little bit more support to reach your goal weight. If you’ve been tolerating the medication well with minimal side effects, your clinician may recommend increasing to 7.2mg.
If you’re on a lower Wegovy dose (such as 0.5mg, 1.0mg, or 1.7mg), or are starting out, you would need to continue titrating up to 2.4mg first. From there, your provider will assess whether you’re a good candidate to move on to 7.2mg.
If you're switching from Mounjaro:
You can speak to your provider about transitioning to Wegovy. If suitable, they will guide you through the appropriate titration schedule to reach 7.2mg.
At Voy, your clinician will work with you to determine whether this dose is right for you based on your progress, side effects, and goals.
What if I’m happy with my current dose?
If you're seeing good results on your current dose, with steady weight loss, strong appetite control, and minimal side effects, there’s no need to change. You don’t have to move up to a higher dose like 7.2mg unless you feel you need more appetite suppression.
If things ever plateau in the future or your goals change, you can always speak to your clinician about whether increasing your dose might be the right next step.
Side effects of Wegovy 7.2mg
The most common side effects with Wegovy 7.2mg are digestive ones, including nausea, constipation, and diarrhoea. These are similar to what’s seen at the 2.4mg dose and with other GLP-1 medications like Mounjaro. They’re typically mild to moderate in severity and tend to settle over time as the body adjusts to the higher dose.
Some people also reported symptoms like tingling or skin sensitivity (known as dysesthesia). These occurred more frequently at the higher dose, but most were mild to moderate. Reassuringly, over 85% of people recovered while staying on treatment.
In terms of overall tolerability, Wegovy 7.2mg performed well. In the STEP UP trial:
- 5.4% of users on 7.2mg stopped treatment due to side effects
- This compares to 4.0% on 2.4mg
- And 6.2% on Mounjaro 15mg in separate studies
If you’re already tolerating Wegovy well, there’s a good chance you’ll do well on 7.2mg too. Just keep in mind that as doses increase, side effects may become more noticeable in the first few weeks while your body adjusts.
Why choose Voy?
If you're thinking about starting Wegovy 7.2mg, you're in expert hands with Voy. We're not just a prescription service, we're your partner throughout your entire weight loss journey.
Here's what sets us apart:
- Free, fast delivery — straight to your door in secure, discreet packaging
- Support within minutes — speak to a clinician on our hotline or via live chat
- Smart in-app tools — track your weight, appetite, and progress, log injection days, and access expert content including videos, tips, and nutrition advice
- 1-to-1 personalised coaching — expert support across nutrition, behaviour, and lifestyle
- Money-back guarantee — if it’s not right for you, we’ll help you find what is
Research shows that people taking GLP-1 medications lose 53% more weight on Voy’s science-backed programme, compared to people who use the medication by itself.
Thousands of patients trust Voy for safe, clinically-backed weight loss and we’re here to help you reach your goals too. Take this short quiz to see if our programme could be the right fit for you.
¹